Last reviewed · How we verify
Insulin degludec, Tresiba
Insulin degludec, Tresiba is a Biologic drug developed by Sunshine Lake Pharma Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Insulin degludec, Tresiba |
|---|---|
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes (PHASE1)
- The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants. (NA)
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin (PHASE2)
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes (PHASE4)
- Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes (PHASE2)
- Single-ascending Dose Study of HEC-151 Injection (PHASE1)
- A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) (PHASE1)
- A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin degludec, Tresiba CI brief — competitive landscape report
- Insulin degludec, Tresiba updates RSS · CI watch RSS
- Sunshine Lake Pharma Co., Ltd. portfolio CI
Frequently asked questions about Insulin degludec, Tresiba
What is Insulin degludec, Tresiba?
Insulin degludec, Tresiba is a Biologic drug developed by Sunshine Lake Pharma Co., Ltd..
Who makes Insulin degludec, Tresiba?
Insulin degludec, Tresiba is developed by Sunshine Lake Pharma Co., Ltd. (see full Sunshine Lake Pharma Co., Ltd. pipeline at /company/sunshine-lake-pharma-co-ltd).
What development phase is Insulin degludec, Tresiba in?
Insulin degludec, Tresiba is in Phase 1.